Arcturus Therapeutics Holdings Inc. financial data

Symbol
ARCT on Nasdaq
Industry
Pharmaceutical Preparations
Location
10628 Science Center Drive, Suite 250, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 410 % +15.9%
Debt-to-equity 56.8 % -18.2%
Return On Equity -38.7 % -180%
Return On Assets -24.7 % -186%
Operating Margin -99.1 % -460%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.9 M shares +1.36%
Common Stock, Shares, Outstanding 26.9 M shares +1.36%
Entity Public Float 692 M USD +84.1%
Common Stock, Value, Issued 27 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 26.9 M shares +1.22%
Weighted Average Number of Shares Outstanding, Diluted 26.9 M shares -1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 125 M USD -55.7%
Research and Development Expense 194 M USD +25.4%
General and Administrative Expense 54 M USD +9.89%
Operating Income (Loss) -123 M USD -260%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -105 M USD -193%
Income Tax Expense (Benefit) 2.1 M USD +61.8%
Net Income (Loss) Attributable to Parent -107 M USD -196%
Earnings Per Share, Basic -4.03 USD/shares -196%
Earnings Per Share, Diluted -3.99 USD/shares -196%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 288 M USD -12.1%
Accounts Receivable, after Allowance for Credit Loss, Current 27.1 M USD -70.7%
Assets, Current 376 M USD -11.5%
Property, Plant and Equipment, Net 11.8 M USD -6.9%
Operating Lease, Right-of-Use Asset 29.4 M USD -6.79%
Assets 419 M USD -11%
Accounts Payable, Current 9.14 M USD -52.7%
Employee-related Liabilities, Current 7.1 M USD +6.22%
Accrued Liabilities, Current 34.8 M USD +7.67%
Liabilities, Current 115 M USD +28.1%
Operating Lease, Liability, Noncurrent 27.7 M USD -5.26%
Other Liabilities, Noncurrent 497 K USD -82.3%
Liabilities 155 M USD +9.37%
Retained Earnings (Accumulated Deficit) -395 M USD -37.3%
Stockholders' Equity Attributable to Parent 264 M USD -19.8%
Liabilities and Equity 419 M USD -11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.56 M USD +84.5%
Net Cash Provided by (Used in) Financing Activities 2.19 M USD
Net Cash Provided by (Used in) Investing Activities -240 K USD +65.3%
Common Stock, Shares Authorized 60 M shares 0%
Common Stock, Shares, Issued 26.9 M shares +1.36%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.61 M USD +94.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 345 M USD +4.61%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.13 M USD +162%
Deferred Tax Assets, Valuation Allowance 109 M USD +10.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 117 M USD +9.25%
Operating Lease, Liability 31.9 M USD -3.77%
Payments to Acquire Property, Plant, and Equipment 240 K USD -65.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -107 M USD -196%
Lessee, Operating Lease, Liability, to be Paid 38.3 M USD -5.98%
Property, Plant and Equipment, Gross 20.9 M USD +10.2%
Operating Lease, Liability, Current 4.27 M USD +7.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.27 M USD +31.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.02 M USD -11.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.33 M USD -15.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.6 M USD -10.4%
Deferred Tax Assets, Operating Loss Carryforwards 19.1 M USD -60%
Current Income Tax Expense (Benefit) 1.84 M USD +41.7%
Unrecognized Tax Benefits 3.6 M USD +24.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.71 M USD +3%
Additional Paid in Capital 659 M USD +6.82%
Current State and Local Tax Expense (Benefit) 589 K USD +239%
Current Federal Tax Expense (Benefit) 1.25 M USD +11.2%
Share-based Payment Arrangement, Expense 36.6 M USD +16.3%